Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

19.40USD
6:19pm BST
Change (% chg)

$0.97 (+5.26%)
Prev Close
$18.43
Open
$18.53
Day's High
$19.40
Day's Low
$18.27
Volume
27,105
Avg. Vol
95,571
52-wk High
$24.78
52-wk Low
$11.45

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

Beta: --
Market Cap(Mil.): $1,165.38
Shares Outstanding(Mil.): 63.23
Dividend: --
Yield (%): --

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 52.11 53.45
EPS (TTM): -2.77 -- --
ROI: -68.89 12.01 11.71
ROE: -88.38 13.29 16.35

Earnings vs. Estimates